Conquering Diseases

Investigational Drug to Treat Social Behavior and Communication Deficits in Children with Autism Spectrum Disorder

Description

Seeking children aged 5-17 years with an Autism Spectrum Disorder (ASD) for a study of the safety and effectiveness of investigational drug to treat social behavior and communication deficits.

Overview

We are studying the safety and how well an investigational drug treat social behavior and communication deficits in children with autism spectrum disorder (ASD). We will compare a low dose, a high dose, and a pill without any medication.

What we're hoping for

We hope to assess whether the investigational drug is safe and effective in treating social behavior and communication deficits in children with ASD by blocking a brain receptor of a hormone associated with socialization

Additional Information

ClinicalTrials.gov Identifier: NCT02901431

 Principal Investigator

Jean  Frazier, MD

UMass Memorial Health Care

 Study Contact

Ann  Foley

774-455-4103

ann.foley@umassmed.edu

 Location

UMMS University Campus

55 Lake Ave North 

Worcester,MA 01655

508-856-8989